VitaVitro Overview
- Year Founded
-
2015

- Status
-
Private
- Latest Deal Type
-
Series C
- Latest Deal Amount
-
$15.4M
- Investors
-
10
VitaVitro General Information
Description
Developer of assisted reproductive technology intended to solve infertility problem. The company's main business includes the entire process from egg retrieval, freezing, culture to embryo transfer, helping clients get the best quality embryos and increase the pregnancy rate.
Contact Information
Website
www.vitavitro.cnCorporate Office
- Room 601, Building B, Haikexing Strategic Emerging Industrial Park
- 16 Baoshan Road, Pingshan District
- Shenzhen, Guangdong
- China
Corporate Office
- Room 601, Building B, Haikexing Strategic Emerging Industrial Park
- 16 Baoshan Road, Pingshan District
- Shenzhen, Guangdong
- China
VitaVitro Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
5. Later Stage VC (Series C) | 07-Sep-2021 | $15.4M | Completed | Generating Revenue | ||
4. Early Stage VC (Series B) | 09-Jun-2020 | Completed | Generating Revenue | |||
3. Early Stage VC (Series A) | 14-Jan-2019 | Completed | Generating Revenue | |||
2. Early Stage VC | 13-Oct-2017 | Completed | Generating Revenue | |||
1. Early Stage VC | 17-Aug-2016 | Completed | Startup |
VitaVitro Patents
VitaVitro Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
DE-202021004064-U1 | A cell culture dish | Active | 02-Jun-2020 | ||
EP-3919609-A1 | Cell culture dish | Inactive | 02-Jun-2020 | ||
US-20220056386-A1 | Cell culture dish | Inactive | 02-Jun-2020 | ||
EP-3760704-A1 | Microfluidic chip and microfluidic device for physically and chemically treating single cell, and method for physically and chemically treating single cell by using microfluidic chip and microfluidic device | Pending | 12-Jun-2018 | ||
EP-3760704-A4 | Microfluidic chip and microfluidic device for physically and chemically treating single cell, and method for physically and chemically treating single cell by using microfluidic chip and microfluidic device | Pending | 12-Jun-2018 | B01L3/502738 |
VitaVitro Investors (10)
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
---|---|---|---|---|
CICC Capital | PE/Buyout | Minority | ||
RFund | Venture Capital | Minority | ||
Shanghai Zhangjiang Science & Technology Venture Capital | Corporate Venture Capital | Minority | ||
Dalton Venture | Venture Capital | Minority | ||
Midas Capital (China) | Venture Capital | Minority |
VitaVitro FAQs
-
When was VitaVitro founded?
VitaVitro was founded in 2015.
-
Where is VitaVitro headquartered?
VitaVitro is headquartered in Shenzhen, China.
-
What industry is VitaVitro in?
VitaVitro’s primary industry is Laboratory Services (Healthcare).
-
Is VitaVitro a private or public company?
VitaVitro is a Private company.
-
What is VitaVitro’s current revenue?
The current revenue for VitaVitro is
. -
How much funding has VitaVitro raised over time?
VitaVitro has raised $15.4M.
-
Who are VitaVitro’s investors?
CICC Capital, RFund, Shanghai Zhangjiang Science & Technology Venture Capital, Dalton Venture, and Midas Capital (China) are 5 of 10 investors who have invested in VitaVitro.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »